In our study, we incubated CD8+ T cells and DCs with targeted C4‐2 cells and acquired cocultured CD8+ T cells that were supposed to have a specific tumour‐killing function, which was validated by comparing BLIs, tumour volumes and survival time in different treatment groups in vivo. This evidence concerns the gene CD8A and neoplasm.